Cellectis (CLLS) Change in Receivables (2015 - 2026)

Cellectis (CLLS) recorded quarterly Change in Receivables of $7.9 million in Q1 2026, up 116.45% quarter-over-quarter from $3.7 million in Q3 2025, and up 3550.0% on a YoY basis from $217397.3 in Q1 2025.

Cellectis (CLLS) Change in Receivables (2015 - 2026) Analysis & Trends

Cellectis' Change in Receivables history runs 12 years deep, the most recent figure standing at $7.9 million for Q1 2026.

  • In Q1 2026, Change in Receivables rose 3550.0% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $9.5 million (down 85.59% YoY), while the FY2024 annual figure was $52.6 million, up 2235.52% from the prior year.
  • Change in Receivables was $7.9 million for Q1 2026 at Cellectis, up from $3.7 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $61.4 million in Q2 2024 to a low of -$13.5 million in Q1 2024.
  • Historically, Change in Receivables has averaged $3.8 million across 5 years, with a median of $171500.0 in 2022.
  • The sharpest annual moves came in 2023 and 2026: Change in Receivables slumped 3769.7% in 2023, then soared 3550.0% in 2026.
  • A 5-year view of Change in Receivables shows it stood at $578000.0 in 2022, then soared by 203.29% to $1.8 million in 2023, then surged by 144.78% to $4.3 million in 2024, then slipped by 14.57% to $3.7 million in 2025, then soared by 116.45% to $7.9 million in 2026.
  • The last three Change in Receivables figures came in at $7.9 million (Q1 2026), $3.7 million (Q3 2025), and -$1.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 22,529.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -39.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -4.08 Mn
10 Cellectis 17.40 Bn 17.21 Bn - 7.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.94 Mn
Mar 31, 2026 7.94 Mn
Sep 30, 2025 3.67 Mn
Sep 30, 2025 3.67 Mn
Jun 30, 2025 -1.88 Mn
Jun 30, 2025 -1.88 Mn
Mar 31, 2025 -230,000.00
Mar 31, 2025 -230,000.00
Dec 31, 2024 4.29 Mn
Dec 31, 2024 4.29 Mn
Sep 30, 2024 376,000.00
Sep 30, 2024 376,000.00
Jun 30, 2024 61.39 Mn
Jun 30, 2024 61.39 Mn
Mar 31, 2024 -13.46 Mn
Mar 31, 2024 -13.46 Mn
Dec 31, 2023 1.75 Mn
Dec 31, 2023 1.75 Mn
Sep 30, 2023 -497,000.00
Sep 30, 2023 -497,000.00